This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Perronne, C Articles by Vilde, J L Search for Related Content PubMed PubMed Citation Articles by Perronne, C Articles by Vilde, J L

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1990 August; 34(8): 1508-1511

Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages.

Institut National de la Santé et de la Recherche Médicale Unité 13, Groupe Hospitalier Bichat-Claude Bernard, Paris, France.

ABSTRACT

The activities of clarithromycin, sulfisoxazole, and rifabutin against three virulent strains of Mycobacterium avium complex isolated from patients with acquired immunodeficiency syndrome were evaluated in a model of intracellular infection. Human monocyte-derived macrophages were infected at day 6 of culture with M. avium complex. Intracellular bacteria were counted 60 min after inoculation. Extra- and intracellular bacteria were counted at days 4 and 7 after inoculation. The concentrations used were 4 micrograms of clarithromycin per ml (MICs for the three strains, 4, 4, and 4 micrograms/ml), 50 micrograms of sulfisoxazole per ml (MICs, 50, 25, and 25 micrograms/ml), and 0.5 micrograms of rifabutin per ml (MICs, 2, 0.5, and 0.5 micrograms/ml). Compared with controls, clarithromycin and rifabutin slowed the intracellular replication of the three strains (at day 7 after inoculation, P was less than 0.01 for the first strain and less than 0.001 for the two others). Sulfisoxazole was ineffective against the three strains. Clarithromycin was as effective as rifabutin. Clarithromycin plus rifabutin was as effective as each single agent. Clarithromycin plus sulfisoxazole was as effective as clarithromycin alone.

This article has been cited by other articles:

• Weller, T. M. A., Andrews, J. M., Jevons, G., Wise, R. (2002). The in vitro activity of BMS-284756, a new des-fluorinated quinolone. J Antimicrob Chemother 49: 177-184 [Abstract] [Full Text]  
• Vacher, S., Pellegrin, J. L., Leblanc, F., Fourche, J., Maugein, J. (1999). Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin. J Antimicrob Chemother 44: 647-652 [Abstract] [Full Text]